Cargando…

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models

Clinical evidences show sex differences in risk of developing depressive disorders as well as effect of antidepressants in depression treatment. However, whether such a sex-dependent risk of depression and efficacy of antidepressants is dependent on endogenous estrogen level remain elusive. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yong, Ma, Lei, Jiang, Wei, Li, Yuhong, Wang, Gang, Li, Rena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671501/ https://www.ncbi.nlm.nih.gov/pubmed/29163055 http://dx.doi.org/10.3389/fncel.2017.00344

Ejemplares similares

Sex Differences in Antidepressant Effect of Sertraline in Transgenic Mouse Models
por: Ma, Lei, et al.
Publicado: (2019)

Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat
por: McLaurin, Kristen A., et al.
Publicado: (2017)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer’s disease and the potential role of local estrogens
por: Hu, Yu-Ting, et al.
Publicado: (2023)

Erratum: Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer's disease and the potential role of local estrogens
Publicado: (2023)

Sex Differences in Depression Caused by Early Life Stress and Related Mechanisms
por: An, Xianquan, et al.
Publicado: (2022)

Attributes of response in depressed patients switched to treatment with duloxetine
por: Sagman, D, et al.
Publicado: (2011)

Depression Treatment with Duloxetine and Reduction of Inability to Work
por: Happich, Michael, et al.
Publicado: (2012)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Synergistic Analgesia of Duloxetine and Celecoxib in the Mouse Formalin Test: A Combination Analysis
por: Sun, Yong-Hai, et al.
Publicado: (2013)

Efficacy of Duloxetine in Patients with Chronic Pain Conditions
por: Skljarevski, Vladimir, et al.
Publicado: (2011)

The anterior cingulate cortex contributes to the analgesic rather than the anxiolytic effects of duloxetine in chronic pain-induced anxiety
por: Li, Chenglin, et al.
Publicado: (2022)

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
por: Mallinckrodt, Craig H, et al.
Publicado: (2005)

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach
por: Maciaszek, Julian, et al.
Publicado: (2023)

The comparison of sex differences in depression-like behaviors and neuroinflammatory changes in a rat model of depression induced by chronic stress
por: Xia, Juan, et al.
Publicado: (2023)

Evaluation of efficacy of duloxetine in stress urinary incontinence in women
por: Deepak, P., et al.
Publicado: (2011)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada, Eiji, et al.
Publicado: (2015)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Sex Differences in the White Matter and Myelinated Fibers of APP/PS1 Mice and the Effects of Running Exercise on the Sex Differences of AD Mice
por: Zhou, Chun-ni, et al.
Publicado: (2018)

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
por: Wise, T N, et al.
Publicado: (2007)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
por: Boutajangout, Allal, et al.
Publicado: (2019)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2011)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
por: Norman, Trevor R, et al.
Publicado: (2010)

Genotoxic and oxidative effect of duloxetine on mouse brain and liver tissues
por: Álvarez-González, Isela, et al.
Publicado: (2021)

Mapping Transgene Insertion Sites Reveals Complex Interactions Between Mouse Transgenes and Neighboring Endogenous Genes
por: Laboulaye, Mallory A., et al.
Publicado: (2018)

Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis
por: Ma, Xuezhi, et al.
Publicado: (2023)

Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial
por: WANG, Zhiyang, et al.
Publicado: (2015)

Duloxetine hydrochloride
por: Bhadbhade, Mohan, et al.
Publicado: (2009)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Effects of Duloxetine Treatment on Cognitive Flexibility and BDNF Expression in the mPFC of Adult Male Mice Exposed to Social Stress during Adolescence
por: Xu, Hang, et al.
Publicado: (2016)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Sex differences in depression during pregnancy and the postpartum period
por: Sundström Poromaa, Inger, et al.
Publicado: (2016)

Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2010)

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011)

The Effect of Initial Duloxetine Dosing Strategy on Nausea in Korean Patients with Major Depressive Disorder
por: Lee, Min-Soo, et al.
Publicado: (2012)

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary
por: Ball, Susan G, et al.
Publicado: (2013)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

Transgenic mouse lines for non-invasive ratiometric monitoring of intracellular chloride
por: Batti, Laura, et al.
Publicado: (2013)

Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease
por: Fainstein, Nina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_52e65taimlbv18ob27oippfqak